Tag: Steve Jobs and neuroendocrine tumor treatment

pfizer logo1

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

May 20, 2011

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to …

READ MORE
Pfizer logo

Breaking News: FDA Approves Pfizer’s Sutent for Pancreatic NET Cancer Patients

May 20, 2011

The US Food and Drug Administration today announced approval of Pfizer’s Sutent (sunitinib) for advanced pancreatic neuroendocrine tumor cancer patients with tumors that cannot be removed by surgery or that have spread  (metastasized) to …

READ MORE

Fortune Reports That Steve Jobs Sought Neuroendocrine Cancer Treatment in Switzerland

January 18, 2011

Fortune reported today, January 18, 2011, that Apple’s CEO Steve Jobs went to Basel, Switzerland in 2009 seeking treatment for neuroendocrine cancer. Read the story HERE.…

READ MORE